BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19640292)

  • 1. Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon.
    Sayang C; Gausseres M; Vernazza-Licht N; Malvy D; Bley D; Millet P
    Malar J; 2009 Jul; 8():176. PubMed ID: 19640292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon.
    Sayang C; Gausseres M; Vernazza-Licht N; Malvy D; Bley D; Millet P
    Malar J; 2009 Jul; 8():174. PubMed ID: 19640283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi.
    Amuasi JH; Diap G; Blay-Nguah S; Boakye I; Karikari PE; Dismas B; Karenzo J; Nsabiyumva L; Louie KS; Kiechel JR
    Malar J; 2011 Feb; 10():34. PubMed ID: 21310057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
    Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
    J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to malaria diagnosis and treatment guidelines among healthcare workers in Ogun State, Nigeria.
    Bamiselu OF; Ajayi I; Fawole O; Dairo D; Ajumobi O; Oladimeji A; Steven Y
    BMC Public Health; 2016 Aug; 16(1):828. PubMed ID: 27538947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.
    Amuasi JH; Diap G; Nguah SB; Karikari P; Boakye I; Jambai A; Lahai WK; Louie KS; Kiechel JR
    PLoS One; 2012; 7(10):e47733. PubMed ID: 23133522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in malaria case management following changes in the treatment policy to artemisinin combination therapy at the Mbakong Health Centre, Cameroon 2006-2012: a retrospective study.
    Ndong IC; Reenen Mv; Boakye DA; Mbacham WF; Grobler AF
    Acta Trop; 2015 Oct; 150():100-6. PubMed ID: 26095044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction.
    Gerstl S; Cohuet S; Edoh K; Brasher C; Lesage A; Guthmann JP; Checchi F
    Malar J; 2007 Jul; 6():94. PubMed ID: 17640357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of artesunate and amodiaquine in African children.
    Stepniewska K; Taylor W; Sirima SB; Ouedraogo EB; Ouedraogo A; Gansané A; Simpson JA; Morgan CC; White NJ; Kiechel JR
    Malar J; 2009 Aug; 8():200. PubMed ID: 19691851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
    Whegang SY; Tahar R; Foumane VN; Soula G; Gwét H; Thalabard JC; Basco LK
    Malar J; 2010 Feb; 9():56. PubMed ID: 20170477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: implications for artemisinin-based combination therapy deployment.
    Kwansa-Bentum B; Ayi I; Suzuki T; Otchere J; Kumagai T; Anyan WK; Asahi H; Akao N; Wilson MD; Boakye DA; Ohta N
    Trop Med Int Health; 2011 Oct; 16(10):1215-24. PubMed ID: 21740487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative and preventive treatment of uncomplicated malaria in public health institutions in Cameroon.
    Ndumbe PM
    Eur J Epidemiol; 1989 Jun; 5(2):183-8. PubMed ID: 2767226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
    Mbacham WF; Evehe MS; Netongo PM; Ateh IA; Mimche PN; Ajua A; Nji AM; Irenee D; Echouffo-Tcheugui JB; Tawe B; Hallett R; Roper C; Targett G; Greenwood B
    Malar J; 2010 Jan; 9():34. PubMed ID: 20105282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy.
    Asante KP; Abokyi L; Zandoh C; Owusu R; Awini E; Sulemana A; Amenga-Etego S; Adda R; Boahen O; Segbaya S; Mahama E; Bart-Plange C; Chandramohan D; Owusu-Agyei S
    BMC Public Health; 2010 Jul; 10():409. PubMed ID: 20624306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana.
    Abuaku B; Duah N; Quaye L; Quashie N; Malm K; Bart-Plange C; Koram K
    Malar J; 2016 Jan; 15():6. PubMed ID: 26728096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.